5.05762

(+/-)-Clopidogrel Hydrogensulfate

• 同義詞: (+/-)-Clopidogrel Hydrogensulfate, Purinergic P2Y12 Receptor Antagonist, (+/-)-Clopidogrel, Plavix
• 經驗公式（希爾表示法）: C₁₆H₁₆ClNO₂S · xH₂SO₄
• CAS號碼: 135046-48-9
• 分子量：: 321.82 (free base basis)
• MDL號碼: MFCD05865229
• 分類程式碼代碼: 12352200
• NACRES: NA.77

屬性

• 化驗: ≥98% (HPLC)
• 品質等級: 100
• 形狀: powder
• 製造商／商標名: Calbiochem^®
• 儲存條件: OK to freeze; protect from light
• 顏色: white
• 溶解度: DMSO: 25 mg/mL
• 儲存溫度: 2-8°C
• SMILES 字串: [S](=O)(=O)([O-])O.[s]1c2c(cc1)C[N+H](CC2)C(c3c(cccc3)Cl)C(=O)OC
• InChI: 1S/C16H16ClNO2S.H2O4S/c1-20-16(19)15(12-4-2-3-5-13(12)17)18-8-6-14-11(10-18)7-9-21-14;1-5(2,3)4/h2-5,7,9,15H,6,8,10H2,1H3;(H2,1,2,3,4)
• InChI 密鑰: FDEODCTUSIWGLK-UHFFFAOYSA-N

描述

一般說明

A thienopyridine compound that acts as a specific irreversible inhibitor of purinergic P2Y₁₂ receptors. Blocks ADP-induced platelet aggregation and serves as an anti-thrombotic agent. Shown to reduce vascular inflammation and angiotensin II induced-abdominal aortic aneurysm progression. Clopidogrel is a prodrug that requires activation by CYP enzyme system to produce its pharmacologically active metabolite.

生化／生理作用

Primary Target
P2Y₁₂

Reversible: no

警告

Toxicity: Standard Handling (A)

重構

Following reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 3 months at -20°C.

其他說明

Liu, O., et al. 2012. PLoS One.7, e51707.

Savi, P., et al. 2005. Semin. Thromb. Hemost.31, 174.

法律資訊

CALBIOCHEM is a registered trademark of Merck KGaA, Darmstadt, Germany

安全資訊

• 象形圖: GHS05,GHS09
• 訊號詞: Danger
• 危險聲明: H314 - H411
• 防範說明: P260 - P273 - P280 - P303 + P361 + P353 - P304 + P340 + P310 - P305 + P351 + P338
• 危險分類: Aquatic Chronic 2 - Eye Dam. 1 - Skin Corr. 1B
• 儲存類別代碼: 8A - Combustible, corrosive hazardous materials
• 水污染物質分類（WGK）: WGK 3
• 閃點（°F）: Not applicable
• 閃點（°C）: Not applicable